Skip to main content
. 2018 May 8;16:119. doi: 10.1186/s12967-018-1499-2

Table 3.

Overview of pharmaceutical companies contributing to IMI

Total number of teams active in IMI projects
Sanofi 51
GlaxoSmithKline 47
Johnson & Johnson 46
AstraZeneca 44
Novartis 36
Pfizer 34
Eli Lilly 32
Roche 31
Bayer 29
Boehringer Ingelheim 28
UCB 25
Novo Nordisk 21
Merck 20
Amgen 16
AbbVie 13
Merck & Co. 10
Takeda 7
BristolMyersSquibb 5